Clinical Trial Update: DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update for the DIAN-TU Amyloid Removal Trial in dominantly inherited Alzheimer's disease. The study status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease Familial

Snippet

Sponsor: Washington University School of Medicine | Conditions: Alzheimer's Disease, Dementia | Phase 3 | Status: ACTIVE_NOT_RECRUITING